Association of Programmed Death 1 Protein Ligand (PD-L1) Expression With Prognosis in Merkel Cell Carcinoma

Background: Merkel cell carcinoma (MCC) is a rare neuroendocrine skin cancer. Prior to the advent of immunotherapy, treatment options were limited. In our study, we evaluate the impact of tumor cell PD-L1 expression and tumor immune microenvironment on survival in MCC patients who were not treated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Glenn J., Kacew, Alec J., Tanguturi, Anusha R., Grote, Hans J., Vergara, Victoria, Brunkhorst, Beatrice, Rabinowits, Guilherme, Thakuria, Manisha, LeBoeuf, Nicole R., Ihling, Christian, DeCaprio, James A., Lorch, Jochen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291775/
https://www.ncbi.nlm.nih.gov/pubmed/32582722
http://dx.doi.org/10.3389/fmed.2020.00198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291775/
https://www.ncbi.nlm.nih.gov/pubmed/32582722
http://dx.doi.org/10.3389/fmed.2020.00198

Ejemplares similares